AUROBINDO PHARMA
|
The Current P/S Ratio of AUROBINDO PHARMA is 2.11.
| Share Price | ₹1,180.3 | Jan 14,2026 |
| Market Cap | ₹68,548.9 Cr | |
| Sales-TTM | ₹32,514.5 Cr | TTM-Consolidated Results |
| Price/Sales | 2.11x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of AUROBINDO PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹68,548.9 Cr] as on Jan 14,2026
(/) Sales [ ₹32,514.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.11x ]
Thus, for AUROBINDO PHARMA , the investors are currently willing to pay '2.11 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of AUROBINDO PHARMA !
The chart below summarizes the trend in P/S Ratio of AUROBINDO PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of AUROBINDO PHARMA
PS Ratio Performance Analysis for AUROBINDO PHARMA
- AUROBINDO PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.86x.
- AUROBINDO PHARMA 's operated at median p/e ratio of 2.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, AUROBINDO PHARMA 's p/e ratio peaked in Mar2024 at 2.2x.
- AUROBINDO PHARMA 's p/e ratio hit its five-year low in Mar2023 of 1.22x.
How does AUROBINDO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| AUROBINDO PHARMA | 32,514.5 | 2.11 | 68,548.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.42 | 408,019.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.83 | 168,752.0 |
| CIPLA LTD | 28,349.6 | 4.09 | 115,883.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.07 | 135,542.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.89 | 99,024.7 |
| MANKIND PHARMA LTD | 13,576.9 | 6.82 | 92,629.3 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.63 | 88,951.1 |
| LUPIN LTD | 24,750.7 | 4.05 | 100,267.0 |
| ABBOTT INDIA LTD | 6,714.4 | 8.83 | 59,284.8 |
| ALKEM LABORATORIES LTD | 13,890.2 | 5.02 | 69,690.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AUROBINDO PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.11x |
| Max industry PS | 16.83x |
| Median industry PS | 5.02x |
| Average industry PS | 6.61x |
You may also like the below Video Courses